Regulations.gov document

Patent Term Extension Application from Theravance Biopharma R&D IP, LLC

Other · FDA-2019-E-5658 · posted Dec 2, 2019

Key facts

Document ID FDA-2019-E-5658-0001
Title Patent Term Extension Application from Theravance Biopharma R&D IP, LLC
Document type Other
Subtype Application
Agency FDA
Docket FDA-2019-E-5658
Posted Dec 2, 2019
Comment period opens Dec 2, 2019

At a glance

  • None Public comments on this docket

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Regulations.gov documents

Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.

Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date:

Browse all Regulations.gov documents